Hi, I'm planning to induce sporadic Alzheimer's disease (AD) in male Sprague Dawley rats (3 months old, 270-350g) through bilateral intracerebroventricular microinjection of 3 mg/kg streptozotocin in the following coordinates; 0.9 mm posterior to bregma, 1.5 mm lateral to the sagittal suture, 3.6 mm beneath the surface of the brain. I need to know whether I need to do brain imaging for every single rats to validate the site of injection is within the desired site. Since the weight varies individually, i afraid the brain size might vary as well. Therefore, the drug may not be injected consistently to the same site in all rats. However, if we validate each rats, my concern is that we might not have enough brain samples to conduct the biochemical assessments as we will loss some brain tissues to the validation process.
Thank you.